Abstract
Nonsteroidal antinflammatory drugs (NSAIDs) inhibit prostaglandin formation by cyclooxygenases (COX) 1 and 2. NSAIDs selective for inhibition of COX-2 are less likely than traditional drugs to cause serious gastrointestinal adverse effects, but predispose to adverse cardiovascular events, such as heart failure, myocardial infarction, and stroke. Evidence from human pharmacology and genetics, genetically manipulated rodents, and other animal models and randomized trials indicates that this is consequent to suppression of COX-2-dependent cardioprotective prostagladins, particularly prostacyclin. Lessons drawn from how this saga unfolded are relevant to how we approach drug surveillance and regulation, integrate diversifed forms of information and might pursue a more personalized approach to drug efficacy and risk.
Keywords
MedicineAdverse effectProstacyclinMyocardial infarctionDrugPharmacologyStroke (engine)Heart failureIntensive care medicineBioinformaticsInternal medicineBiology
Affiliated Institutions
Related Publications
Cyclooxygenases: Structural, Cellular, and Molecular Biology
▪ Abstract The prostaglandin endoperoxide H synthases-1 and 2 (PGHS-1 and PGHS-2; also cyclooxygenases-1 and 2, COX-1 and COX-2) catalyze the committed step in prostaglandin syn...
The COXIB Experience: A Look in the Rearview Mirror
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used prescription and nonprescription drugs in the world. The discovery of cyclooxygenase (COX) as the t...
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
Two cyclooxygenase isozymes, COX-1 and -2, are known to catalyze the rate-limiting step of prostaglandin synthesis and are the targets of nonsteroidal antiinflammatory drugs. He...
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Owing to the efficacy in reducing pain and inflammation, non-steroidal anti-inflammatory drugs (NSAIDs) are amongst the most popularly used medicines confirming their position i...
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
The magnitude of effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on specific cardiovascular and renal outcomes and whether heterogeneity is based on key baseline ch...
Publication Info
- Year
- 2010
- Type
- review
- Volume
- 61
- Issue
- 1
- Pages
- 17-33
- Citations
- 228
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
228
OpenAlex
Cite This
Tilo Großer,
Ying Yu,
Garret A. FitzGerald
(2010).
Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga.
Annual Review of Medicine
, 61
(1)
, 17-33.
https://doi.org/10.1146/annurev-med-011209-153129
Identifiers
- DOI
- 10.1146/annurev-med-011209-153129